Cargando…

Bevacizumab (Avastin(®)) for the management of anterior chamber neovascularization and neovascular glaucoma

PURPOSE: To establish the efficacy and safety of intravitreal bevacizumab in reducing iris and anterior chamber angle neovascularization and managing neovascular glaucoma. DESIGN: Prospective interventional case series. PATIENT AND METHODS: Eleven eyes of 11 patients with iris and anterior chamber a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brouzas, Dimitrios, Charakidas, Antonios, Moschos, Marilita, Koutsandrea, Chryssanthi, Apostolopoulos, Michael, Baltatzis, Stefanos
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801638/ https://www.ncbi.nlm.nih.gov/pubmed/20054417

Ejemplares similares

Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin(®)) for AMD followed by controlateral sympathetic ophthalmia
por: Brouzas, Dimitrios, et al.
Publicado: (2009)

Choroidal neovascularization due to punctate inner choroidopathy: long-term follow-up and review of literature
por: Brouzas, Dimitrios, et al.
Publicado: (2010)

Intravitreal Bevacizumab (Avastin) as an Adjuvant Treatment in Cases of Neovascular Glaucoma
por: Ghanem, Asaad A., et al.
Publicado: (2009)

Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009)

Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
por: Raghuram, A, et al.
Publicado: (2007)

Intra-cameral injection of Bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye
por: Agarwal, Manisha, et al.
Publicado: (2008)

Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
por: Sachdev, Nishant, et al.
Publicado: (2007)

Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
por: Ladas, Ioannis D, et al.
Publicado: (2009)

Pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits
por: Sinapis, Christos I, et al.
Publicado: (2011)

Nonarteritic anterior ischemic optic neuropathy associated with chronic anemia: a case series of myelodysplastic syndrome patients
por: Brouzas, Dimitrios, et al.
Publicado: (2009)

Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes
por: Adrean, Sean D., et al.
Publicado: (2017)

Is monthly retreatment with intravitreal bevacizumab (Avastin(®)) necessary in neovascular age-related macular degeneration?
por: Ghazi, Nicola G, et al.
Publicado: (2010)

Mechanisms Controlling the Effects of Bevacizumab (Avastin) on the Inhibition of Early but Not Late Formed Corneal Neovascularization
por: Chen, Wei-Li, et al.
Publicado: (2014)

Decompression retinopathy after intravitreal bevacizumab and anterior chamber paracentesis in a patient with neovascular glaucoma
por: Kim, Eung Suk, et al.
Publicado: (2016)

Multifocal VEP and OCT findings in patients with primary open angle glaucoma: A cross-sectional study
por: Moschos, Marilita M, et al.
Publicado: (2012)

The effect of intravitreal bevacizumab (Avastin(®)) on ocular pulse amplitude in neovascular age-related macular degeneration
por: Rechtman, Ehud, et al.
Publicado: (2011)

Metastasis rates and sites after treatment for choroidal melanoma by proton beam irradiation or by enucleation
por: Koutsandrea, Chryssanthi, et al.
Publicado: (2008)

Comparison between the efficacy and side effects of intravitreal versus anterior chamber Bevacizumab injection in neovascular glaucoma patients
por: Ungureanu, E, et al.
Publicado: (2014)

Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma
por: Canut, MI, et al.
Publicado: (2011)

Ocular Decompression Retinopathy after Anterior Chamber Paracentesis for Neovascular Glaucoma
por: Tsai, Yung-En, et al.
Publicado: (2021)

Intraocular lens power calculation in eyes with short axial length
por: Moschos, Marilita M., et al.
Publicado: (2014)

Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma
por: Ha, Jun Young, et al.
Publicado: (2017)

Optical Coherence Tomography Angiography of Foveal Neovascularization in Diabetic Retinopathy
por: Andreanos, Konstantinos, et al.
Publicado: (2018)

Intravitreal bevacizumab for macular edema due to proton beam radiotherapy: Favorable results shown after eighteen months follow-up
por: Loukianou, Eleni, et al.
Publicado: (2010)

Indocyanine green-assisted epiretinal membrane peeling evaluated by optical coherence tomography and multifocal electroretinography
por: Koutsandrea, Chryssanthi N, et al.
Publicado: (2007)

Peripheral sea-fan retinal neovascularization as a manifestation of chronic rhegmatogenous retinal detachment and surgical management
por: Georgalas, Ilias, et al.
Publicado: (2014)

TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands
por: Foss, Alexander, et al.
Publicado: (2020)

The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes
por: Tsikripis, Panagiotis, et al.
Publicado: (2013)

Intravitreal Avastin for Choroidal Neovascularization Associated with Stargardt-Like Retinal Abnormalities in Pseudoxanthoma Elasticum
por: Querques, Giuseppe, et al.
Publicado: (2010)

Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
por: Marey, Hatem M, et al.
Publicado: (2011)

Study of the Effect of Injection Bevacizumab through Various Routes in Neovascular Glaucoma
por: Bhagat, Purvi R, et al.
Publicado: (2016)

Correlation of central corneal thickness and axial length to the optic disc and peripapillary atrophy among healthy individuals, glaucoma and ocular hypertension patients
por: Tomais, George, et al.
Publicado: (2008)

Objective documentation of anterior chamber depth following trabeculectomy and its correlation with intraocular pressure and bleb functionality
por: Diagourtas, Andreas, et al.
Publicado: (2018)

Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
por: Noor, Nina Asrini, et al.
Publicado: (2017)

Vascular Endothelial Growth Factor in Anterior Chamber Liquid Patients with Diabetic Retinopathy, Cataract and Neovascular Glaucoma
por: Kuzmin, Anatoly, et al.
Publicado: (2013)

Intravitreal Bevacizumab for the Treatment of Neovascular Glaucoma Associated With Central Retinal Artery Occlusion
por: Sagong, Min, et al.
Publicado: (2009)

Effect of Preoperative Intravitreal Bevacizumab on the Surgical Outcome of Neovascular Glaucoma at Different Stages
por: Kwon, Junki, et al.
Publicado: (2017)

Assessment of hydroxychloroquine maculopathy after cessation of treatment: an optical coherence tomography and multifocal electroretinography study
por: Moschos, Marilita M, et al.
Publicado: (2015)

The Effect of Bevacizumab on Corneal Neovascularization in Rabbits
por: Kim, Wung-Jae, et al.
Publicado: (2010)

Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma
por: Mandal, Subrata, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_a9oo134csocco5qqim55fuclaa